Association between angiotensinogen gene M235T polymorphism and mitral valve prolapse syndrome in Taiwan Chinese

Journal of Heart Valve Disease

Volumn 11, Issue 6, 2002, Pages 830-836

  Chou, Hsiang Tai ^a   Hung, Jui Sung ^a   Chen, Yng Tay ^a   Shi, Yi Ru ^a   Tsai, Fuu Jen ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSINOGEN; RESTRICTION ENDONUCLEASE;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; DNA POLYMORPHISM; ECHOCARDIOGRAPHY; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE PROLAPSE; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TAIWAN;

ADOLESCENT; ADULT; AGED; ANGIOTENSINOGEN; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; ECHOCARDIOGRAPHY, DOPPLER, COLOR; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY; MITRAL VALVE PROLAPSE; POLYMORPHISM, GENETIC; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SYNDROME; TAIWAN;

EID: 0036855446     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Procacci PM, Savran SV, Schreiter SL, et al. Prevalence of clinical mitral valve Prolapse in 1169 young women. N Engl J Med 1976;294:1086-1088
2. Savage DD, Garrison RJ, Devereux RB, et al. Mitral valve prolapse in the general population, I: epidemiologic features: The Framingham Study. Am Heart J 1983;106:571-575
3. Frable WJ. Mucinous degeneration of the cardiac valves: The 'floppy valve' syndrome. J Thorac Cardiovasc Surg 1969;58:62-70
4. Kern WH, Tucker BL. Myxoid changes in cardiac valves: Pathologic, clinical and ultrastructural studies. Am Heart J 1972;84:294-301
5. Barlow JB, Pocock WA. Mitral Valve prolapse, the specific billowing mitral leaflet syndrome, or an insignificant non-ejection systolic click. Am Heart J 1979;97:277-285
6. Barlow JB, Pocock WA, Marchand P, Denny M. The significance of late systolic murmur. Am Heart J 1963;66:443-452
7. Boudoulas H. Mitral valve prolapse: Etiology, clinical presentation and neuroendocrine function. J Heart Valve Dis 1992;1:175-188
8. Zdrojewski TR, Wyrzykowski B, Krupa-Wojciechowska B. Renin-aldosterone regulation during upright posture in young men with mitral valve prolapse syndrome. J Heart Valve Dis 1995;4:236-241
9. Gould AB, Green B. Kinetics of the human renin and human renin substrate reaction. Cardiovasc Res 1971;5:86-89
10. Eggena P, Barrett JD. Regulation and functional consequences of angiotensinogen gene expression. J Hypertens 1992;10:1307-1311
11. Saavedra JM. Brain and pituitary angiotensin. Endocr Rev 1992;13:329-380
12. Reid IA. Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. Am J Physiol 1992;262:E763-E778
13. Townend JN, Al-Ani M, West JN, et al. Modulation of cardiac autonomic control in humans by angiotensin II. Hypertension 1995;25:1270-1275
14. Dohi Y, Hahn AWA, Boulanger CM, Bühler FR, Lüscher TF. Endothelin stimulated by angiotensin II augments contractility of spontaneously hypertensive rat arteries. Hypertension 1992;19:131-137
15. Saito S, Hirata Y, Emori T, Imai T, Marumo F. Angiotensin II activates endothelial constitutive nitric oxide synthase via AT1 receptors. Hypertens Res 1996;19:201-206
16. Gaillard I, Clauser E, Corvol P. Structure of human angiotensinogen gene. DNA 1989;8:87-99
17. Jeunemaitre X, Soubrier F, Kotelevtsev YV, et al. Molecular basis of human hypertension: Role of angiotensinogen. Cell 1992;71:169-180
18. Caulfield M, Lavender P, Farrall M, et al. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 1994;330:1629-1633
19. Caulfield M, Lavender P, Newell-Price J, et al. Linkage of the angiotensinogen gene locus to human essential hypertension in African Caribbeans. J Clin Invest 1995;96:687-692
20. Katsuva T, Koike G, Yee TW; et al. Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet 1995;345:1600-1603
21. Rodriguez-Perez JC, Rodriguez-Esparragon F, Hernandez-Perera O, et al. Association of angiotensinogen M235T and A(-6)G gene polymorphisms with coronary heart disease with independence of essential hypertension: The PROCAGENE Study. J Am Coll Cardiol 2001;37:1536-1542
22. Henry WL, DeMaria A, Gramiak R. Report of the American Society of Echocardiography committee on nomenclature and standards in 2D echocardiography. Circulation 1980;62:212-220
23. Miyatake K, Izumi S, Okamoto M, et al. Semiquantitative grading of severity of mitral regurgitation by real-time two-dimensional Doppler flow imaging technique. J Am Coll Cardiol 1986;7:82-88
24. Shappell SD, Marshall CE, Brown RE, Bruce TA. Sudden death and the familial occurrence of mid-systolic click, late systolic murmur syndrome. Circulation 1973;48:1128-1134
25. Weiss AN, Mimbs JW, Ludbrook PA, Sobel BE. Echocardiographic detection of mitral valve prolapse; exclusion of false positive diagnosis and determination of inheritance. Circulation 1975;52:1091-1096
26. Devereux RB, Brown WT, Kramer-Fox R, Sachs I. Inheritance of mitral valve prolapse: Effect of age and sex on gene expression. Ann Intern Med 1982;97:826-832
27. Wordsworth P, Ogilvie D, Akhras F, Jackson G, Sykes B. Genetic segregation analysis of familial valve prolapse shows no linkage to fibrillar collagen genes. Br Heart J 1989;61:300-306
28. Disse S, Abergel E, Berrebi A, et al. Mapping of a first locus for autosomal dominant myxomatous mitral valve prolapse to chromosome 16p11.2-p12.1. Am J Hum Genet 1999;65:1242-1251
29. Kyndt F, Schott JJ, Trochu JN, et al. Mapping of X-linked myxomatous valvular dystrophy to chromosome Xq28. Am J Hum Genet 1998;62:627-632
30. Kwok PY, Gu Z. Single nucleotide polymorphism libraries: Why and how are we building them? Mol Med Today 1999;5:538-543
31. Collins FS, Guyer MS, Chakravarti A. Variation on a theme: Cataloging human DNA sequence variation. Science 1997;278:1580-1581
32. Szombathy T, Janoskuti L, Szalai C, et al. Angiotensin II type 1 receptor gene polymorphism and mitral valve prolapse syndrome. Am Heart J 2000;139:101-105
33. 1166 polymorphism is not associated with mitral valve prolapse syndrome in Taiwan Chinese. Circ J 2002;66:163-166
34. Chou HT, Chen YT, Shi YR, Tsai FJ. Association between angiotensin I-converting enzyme gene insertion/deletion polymorphism and mitral valve prolapse syndrome. Am Heart J 2002 (in press).
35. Winkelmann BR, Russ AP, Nauck M, et al. Angiotensinogen M235T polymorphism is associated with plasma angiotensinogen and cardiovascular disease. Am Heart J 1999;137:698-705
36. Young RP, Chan JCN, Poon E, Critchley JAJH, Nicholls G, Cockram CS. Association between albuminuria and angiotensinogen T235 and angiotensin converting enzyme deletion polymorphisms in Chinese NIDDM patients. Diabetes Care 1998;21:431-437
37. Cheung BM, Leung R, Shiu S, Tan KC, Lau CP, Kumana CR. M235T polymorphism of the angiotensinogen gene and hypertension in Chinese. J Hypertens 1998;16:1137-1140
38. Niu T, Yang J, Wang B, et al. Angiotensinogen gene polymorphisms M235T/T174M: No excess transmission to hypertensive Chinese. Hypertension 1999;33:698-702
39. Winkelmann BR, Hager J, Kraus WE, et al. Genetics of coronary heart disease: Current knowledge and research principles. Am Heart J 2000;140:S11-S26